Wikidata

(Q50972210)

English

A 26-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the effect of omalizumab on asthma control in patients with persistent allergic asthma.

scientific article published on 25 January 2012

In more languages

Statements

title
A 26-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the effect of omalizumab on asthma control in patients with persistent allergic asthma. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22277052
retrieved
26 March 2018
reference URL
http://europepmc.org/abstract/MED/22277052

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q50972210&oldid=1231365863"